Profound Medical (PROF) Current Deferred Revenue (2018 - 2026)

Profound Medical's Current Deferred Revenue history runs 9 years deep, the most recent figure standing at $464000.0 for Q1 2026.

• In Q1 2026, Current Deferred Revenue fell 27.04% year-over-year to $464000.0; the TTM figure through Mar 2026 stood at $464000.0 (down 27.04% YoY), while the FY2025 annual figure was $445000.0, up 6.21% from the prior year.
• Current Deferred Revenue was $464000.0 for Q1 2026 at Profound Medical, up from $445000.0 in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $721000.0 in Q4 2023 to a low of $419000.0 in Q4 2024.
• Historically, Current Deferred Revenue has averaged $535500.0 across 5 years, with a median of $467500.0 in 2022.
• The sharpest annual moves came in 2023 and 2024: Current Deferred Revenue soared 53.08% in 2023, then plunged 41.89% in 2024.
• A 5-year view of Current Deferred Revenue shows it stood at $471000.0 in 2022, then soared by 53.08% to $721000.0 in 2023, then tumbled by 41.89% to $419000.0 in 2024, then increased by 6.21% to $445000.0 in 2025, then gained by 4.27% to $464000.0 in 2026.
• The last three Current Deferred Revenue figures came in at $464000.0 (Q1 2026), $445000.0 (Q4 2025), and $434000.0 (Q3 2025), per Business Quant data.